Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review

  • Yu L
  • Li K
  • Zhang X
N/ACitations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

© Yu et al. Lung cancer is the leading cause of cancer-related death. Next-generation metabolomics is becoming a powerful emerging technology for studying the systems biology and chemistry of health and disease. This mini review summarized the main platforms of next-generation metabolomics and its main applications in lung cancer including early diagnosis, pathogenesis, classifications and precision medicine. The period covers between 2009 and August, 2017. The major issues and future directions of metabolomics in lung cancer research and clinical applications were also discussed.

Cite

CITATION STYLE

APA

Yu, L., Li, K., & Zhang, X. (2017). Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review. Oncotarget, 8(70). https://doi.org/10.18632/oncotarget.22404

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free